TY - JOUR
T1 - Assessment of the activity of decoquinate and its quinoline‐ o‐carbamate derivatives against toxoplasma gondii in vitro and in pregnant mice infected with t. Gondii oocysts
AU - Ramseier, Jessica
AU - Imhof, Dennis
AU - Anghel, Nicoleta
AU - Hänggeli, Kai
AU - Beteck, Richard M.
AU - Balmer, Vreni
AU - Ortega‐mora, Luis Miguel
AU - Sanchez‐sanchez, Roberto
AU - Ferre, Ignacio
AU - Haynes, Richard K.
AU - Hemphill, Andrew
N1 - Publisher Copyright:
© 2021 by the author. Licensee MDPI, Basel, Switzerland.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - The quinolone decoquinate (DCQ) is widely used in veterinary practice for the treatment of bacterial and parasitic infections, most notably, coccidiosis in poultry and in ruminants. We have investigated the effects of treatment of Toxoplasma gondii in infected human foreskin fibroblasts (HFF) with DCQ. This induced distinct alterations in the parasite mitochondrion within 24 h, which persisted even after long‐term (500 nM, 52 days) treatment, although there was no parasiticidal effect. Based on the low half‐maximal effective concentration (IC50) of 1.1 nM and the high selectivity index of >5000, the efficacy of oral treatment of pregnant mice experimentally infected with T. gondii oocysts with DCQ at 10 mg/kg/day for 5 days was assessed. However, the treatment had detrimental effects, induced higher neonatal mortality than T. gondii infection alone, and did not prevent vertical transmission. Thus, three quinoline‐O‐carbamate derivatives of DCQ, anticipated to have better physicochemical properties than DCQ, were assessed in vitro. One such compound, RMB060, displayed an exceedingly low IC50 of 0.07 nM, when applied concomitantly with the infection of host cells and had no impact on HFF viability at 10 μM. As was the case for DCQ, RMB060 treatment resulted in the alteration of the mitochondrial matrix and loss of cristae, but the changes became apparent at just 6 h after the commencement of treatment. After 48 h, RMB060 induced the expression of the bradyzoite antigen BAG1, but TEM did not reveal any other features reminiscent of bradyzoites. The exposure of infected cultures to 300 nM RMB060 for 52 days did not result in the complete killing of all tachyzoites, although mitochondria remained ultrastructurally damaged and there was a slower proliferation rate. The treatment of mice infected with T. gondii oocysts with RMB060 did reduce parasite burden in non‐pregnant mice and dams, but vertical transmission to pups could not be prevented.
AB - The quinolone decoquinate (DCQ) is widely used in veterinary practice for the treatment of bacterial and parasitic infections, most notably, coccidiosis in poultry and in ruminants. We have investigated the effects of treatment of Toxoplasma gondii in infected human foreskin fibroblasts (HFF) with DCQ. This induced distinct alterations in the parasite mitochondrion within 24 h, which persisted even after long‐term (500 nM, 52 days) treatment, although there was no parasiticidal effect. Based on the low half‐maximal effective concentration (IC50) of 1.1 nM and the high selectivity index of >5000, the efficacy of oral treatment of pregnant mice experimentally infected with T. gondii oocysts with DCQ at 10 mg/kg/day for 5 days was assessed. However, the treatment had detrimental effects, induced higher neonatal mortality than T. gondii infection alone, and did not prevent vertical transmission. Thus, three quinoline‐O‐carbamate derivatives of DCQ, anticipated to have better physicochemical properties than DCQ, were assessed in vitro. One such compound, RMB060, displayed an exceedingly low IC50 of 0.07 nM, when applied concomitantly with the infection of host cells and had no impact on HFF viability at 10 μM. As was the case for DCQ, RMB060 treatment resulted in the alteration of the mitochondrial matrix and loss of cristae, but the changes became apparent at just 6 h after the commencement of treatment. After 48 h, RMB060 induced the expression of the bradyzoite antigen BAG1, but TEM did not reveal any other features reminiscent of bradyzoites. The exposure of infected cultures to 300 nM RMB060 for 52 days did not result in the complete killing of all tachyzoites, although mitochondria remained ultrastructurally damaged and there was a slower proliferation rate. The treatment of mice infected with T. gondii oocysts with RMB060 did reduce parasite burden in non‐pregnant mice and dams, but vertical transmission to pups could not be prevented.
KW - Bradyzoites
KW - Decoquinate
KW - Oocysts
KW - Proliferation
KW - Quinolone
KW - Resistance
KW - Tachyzoites
KW - Toxoplasma gondii
KW - Vertical transmission
UR - http://www.scopus.com/inward/record.url?scp=85117573721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117573721&partnerID=8YFLogxK
U2 - 10.3390/molecules26216393
DO - 10.3390/molecules26216393
M3 - Article
C2 - 34770802
AN - SCOPUS:85117573721
SN - 1420-3049
VL - 26
JO - Molecules
JF - Molecules
IS - 21
M1 - 6393
ER -